Ekttitab Holding Co SAK: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Ekttitab Holding Co SAKC Announces Subscription Period Extension of its Rights Issue
Ekttitab Holding Co SAKC announced that, regarding the Company's capital increase from KWD 22,862,423 to KWD 31,862,423 through a right share issue to shareholders registered in the Company books as of January 22, 2013 for a nominal value of KWD 0.100 per share, its Board of Directors has decided to extend the period of subscription in the new share for another two weeks to be the last day is February 20, 2013.
Latest Developments for Ekttitab Holding Co SAK
- Share this
- Digg this